<p>Broncus Holding Corp.（香港股票代碼：2216）剛剛發佈了一項公告。</p>
<p>Broncus Holding Corp.宣佈在一般授權下擬發行股份，同意以每股 HK$3.11 配發和發行 105,108,015 股認購股份。這一舉措約佔公司已發行股本的 19.90%，預計將籌集 HK$326.9 百萬的總收入，以支持公司在醫療器械行業的擴展。認購協議的完成需滿足某些條件，建議利益相關者謹慎行事。</p>
<p>（香港股票代碼：2216）的最新分析師評級為持有，目標價格為 HK$3.00。要查看 Broncus Holding Corp.股票的完整分析師預測列表，請訪問 HK:2216 股票預測頁面。</p>
<p><strong>關於 Broncus Holding Corp.的更多信息</strong></p>
<p>Broncus Holding Corp.是一家在開曼羣島註冊的公司，主要專注於醫療器械行業。它通過潛在收購擴展其產品組合，表明其在醫療保健領域的戰略增長重點。</p>
<p><strong>平均交易量：</strong> 3,927,575</p>
<p><strong>技術情緒信號：</strong> 買入</p>
<p><strong>當前市值：</strong> HK$1.73B</p>
<p>要對 2216 股票進行全面評估，請訪問 TipRanks 的股票分析頁面。</p>

堃博醫療-B

<p>Broncus Holding Corp.（香港股票代碼：2216）宣佈擬發行 105,108,015 股認購股份，發行價為每股 3.11 港元，旨在為醫療設備領域的擴展籌集 3.269 億港元。這相當於其已發行股本的約 19.90%。認購的完成需滿足一定條件。分析師目前對該股票的評級為持有，目標價為 3.00 港元。Broncus 專注於通過潛在的醫療保健收購實現增長，市值為 17.3 億港元</p>

<p>Broncus Holding Corp. ( (HK:2216) ) just unveiled an announcement.</p>
<div class="lb-trans"><p>Broncus Holding Corp.（香港股票代碼：2216）剛剛發佈了一項公告。</p>
</div><p>Broncus Holding Corp. announced a proposed issue of shares under a general mandate, agreeing to allot and issue 105,108,015 subscription shares at HK$3.11 per share. This move, representing approximately 19.90% of the company’s issued share capital, is expected to raise gross proceeds of HK$326.9 million, which will support the company’s expansion in the medical devices industry. The completion of the subscription agreements is subject to certain conditions, and stakeholders are advised to exercise caution.</p>
<div class="lb-trans"><p>Broncus Holding Corp.宣佈在一般授權下擬發行股份，同意以每股 HK$3.11 配發和發行 105,108,015 股認購股份。這一舉措約佔公司已發行股本的 19.90%，預計將籌集 HK$326.9 百萬的總收入，以支持公司在醫療器械行業的擴展。認購協議的完成需滿足某些條件，建議利益相關者謹慎行事。</p>
</div><p>The most recent analyst rating on (HK:2216) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Broncus Holding Corp. stock, see the HK:2216 Stock Forecast page.</p>
<div class="lb-trans"><p>（香港股票代碼：2216）的最新分析師評級為持有，目標價格為 HK$3.00。要查看 Broncus Holding Corp.股票的完整分析師預測列表，請訪問 HK:2216 股票預測頁面。</p>
</div><p><strong>More about Broncus Holding Corp.</strong></p>
<div class="lb-trans"><p><strong>關於 Broncus Holding Corp.的更多信息</strong></p>
</div><p>Broncus Holding Corp. is a company incorporated in the Cayman Islands, primarily focused on the medical devices industry. It is involved in expanding its product portfolio through potential acquisitions, indicating a strategic focus on growth within the healthcare sector.</p>
<div class="lb-trans"><p>Broncus Holding Corp.是一家在開曼羣島註冊的公司，主要專注於醫療器械行業。它通過潛在收購擴展其產品組合，表明其在醫療保健領域的戰略增長重點。</p>
</div><p><strong>Average Trading Volume:</strong> 3,927,575</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 3,927,575</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技術情緒信號：</strong> 買入</p>
</div><p><strong>Current Market Cap:</strong> HK$1.73B</p>
<div class="lb-trans"><p><strong>當前市值：</strong> HK$1.73B</p>
</div><p>For a thorough assessment of 2216 stock, go to TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>要對 2216 股票進行全面評估，請訪問 TipRanks 的股票分析頁面。</p>
</div>

堃博控股公司宣佈發行股票以籌集資金用於擴張